SCHEMBL8444476

SCHEMBL8444476

CC(NCCCn1ccnc1)c1cccc(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
ALDH1A1 P00352 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MAOB P27338 1/20 0.54
QPCT Q16769 4/20 0.51
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.48
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
CYP19A1 P11511 1/20 0.47
LMNA P02545 2/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8444374 0.85 ALOX15 (0.55) KMT2AQPCTPOLBSMN1; SMN2ALOX15
SCHEMBL8445916 0.85 QPCT (0.54) ALDH1A1QPCTPOLBSMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL8444444 0.84 QPCT (0.53) ALDH1A1QPCTPOLBSMN1; SMN2LMNA
SCHEMBL8443995 0.84 TP53 (0.52) ALDH1A1QPCTPOLBSMN1; SMN2LMNA
SCHEMBL8444572 0.83 ALDH1A1 (0.51) ALDH1A1QPCTPOLBSMN1; SMN2LMNA
SCHEMBL8443654 0.82 HSD17B10 (0.49) KMT2AMEN1ALDH1A1QPCTPOLB
SCHEMBL8445807 0.81 ALOX15 (0.48) KMT2AQPCTPOLBSMN1; SMN2ALOX15
SCHEMBL8443881 0.81 ADRA2C (0.57) KMT2AMEN1MAOBSMN1; SMN2ALOX15
SCHEMBL8446848 0.81 MAPT (0.51) KMT2AMEN1QPCTSMN1; SMN2ALOX15
Hydrochloric Acid SCHEMBL8443909 0.81 ALOX15 (0.47) KMT2AQPCTPOLBSMN1; SMN2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0618907-B1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS BRITISH TECH GROUP INT (GB) 1999-04-28 EP claimed
CN-1037511-C Therapeutic agents BOOTS CO PLC (GB) 1998-02-25 CN claimed
JP-2633087-B2 1997-07-23 JP claimed
WO-1995022327-A1 USE OF 1-(ARYLALKYLAMINOALKYL) IMIDAZOLES FOR TREATING NEUROLOGICAL DAMAGE KNOLL AG (DE) 1995-08-24 WO claimed
WO-1993013075-A1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS THE BOOTS COMPANY PLC (GB) 1993-07-08 WO claimed
EP-0618907-B1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS BRITISH TECH GROUP INT (GB) 1999-04-28 EP disclosed
CN-1037511-C Therapeutic agents BOOTS CO PLC (GB) 1998-02-25 CN disclosed
US-5547972-A 1-(ARLALKYLAMINOALKYL) IMIDAZOLE DERIVATIVES THE BOOTS COMPANY PLC (GB) 1996-08-20 US disclosed
WO-1995022327-A1 USE OF 1-(ARYLALKYLAMINOALKYL) IMIDAZOLES FOR TREATING NEUROLOGICAL DAMAGE KNOLL AG (DE) 1995-08-24 WO disclosed
CN-1096781-A The therapeutical agent that contains 1-(aralkyl-aminoalkyl) imidazolium compounds BOOTS CO PLC (GB) 1994-12-28 CN disclosed
EP-0618907-A1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS Knoll AG (DE) 1994-10-12 EP disclosed
WO-1993013075-A1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS THE BOOTS COMPANY PLC (GB) 1993-07-08 WO disclosed